pathogen
recognit
ctype
lectin
sever
level
complex
distinguish
might
modul
immun
respons
differ
way
firstli
pathogenassoci
molecular
pattern
repertoir
express
microbi
surfac
determin
interact
specif
receptor
fig
secondli
immun
cell
type
possess
specif
set
pathogenrecognit
receptor
thirdli
chang
cellsurfac
distribut
ctype
lectin
regul
carbohydr
bind
modul
receptor
affin
differ
ligand
crosstalk
receptor
result
network
multimolecular
complex
ad
level
complex
pathogen
recognit
cambi
figdor
jack
et
al
thiel
et
al
see
chap
mbl
defici
genet
determin
predispos
recurr
infect
chronic
inflammatori
diseas
mbl
defici
implic
suscept
cours
viral
bacteri
fungal
protozoan
infect
gener
popul
may
depend
definit
classifi
mbl
defici
underlin
redund
immun
system
mbldiseas
associ
studi
fruit
area
research
implic
role
mbl
infect
inflammatori
autoimmun
diseas
process
mbl
defici
predispos
infect
extracellular
pathogen
autoimmun
diseas
mannosebind
lectin
ctype
serum
lectin
primarili
produc
liver
bouwman
et
al
respons
infect
part
mani
factor
term
http
en
wikipediaorgwikiacutephaseprotein
acut
phase
protein
acut
phase
protein
mbl
made
structur
unit
turn
compos
three
ident
primari
subunit
subunit
consist
ntermin
crosslink
region
collagenlik
domain
ctermin
carbohydraterecognit
domain
crd
chap
turner
hamva
circul
mbl
compos
higherord
oligomer
structur
includ
dimer
trimer
tetram
pentam
hexam
structur
homotrimer
unit
oligomer
configur
structur
unit
allow
mbl
molecul
multipl
crd
facilit
multival
ligand
bind
crd
mbl
structur
ident
abl
bind
rang
oligosaccharid
includ
nacetylglucosamin
dmannos
nacetylmannosamin
lfucos
turner
although
variou
sugar
bound
differ
affin
clusterlik
array
multipl
bind
site
allow
activ
complement
effect
mbl
consid
play
major
role
innat
defens
pathogen
involv
recognit
array
mblbind
carbohydr
microbi
surfac
howev
recent
studi
shown
mbl
also
involv
recognit
selftarget
apoptot
necrot
cell
nauta
et
al
plasma
mbl
associ
mblassoci
serin
proteas
masp
current
three
masp
identifi
chap
mbl
belong
class
collectin
ctype
lectin
superfamili
whose
function
appear
pattern
recognit
first
line
defens
preimmun
host
mbl
recogn
carbohydr
pattern
found
surfac
larg
number
pathogen
microorgan
includ
bacteria
virus
protozoa
fungi
mannosebind
lectin
bind
repeat
sugar
array
surfac
pathogen
multipl
lectin
domain
follow
bind
abl
activ
complement
system
via
associ
serum
proteas
importantli
mbl
activ
complement
system
distinct
third
pathway
independ
gs
gupta
antibodi
complex
tabl
mbl
bind
neutral
carbohydr
microbi
surfac
recognis
carbohydr
mannos
glucos
lfucos
nacetylmannosamin
mannac
nacetylglucosamin
glcnac
oligomeris
mbl
enabl
high
avid
bind
repetit
carbohydr
ligand
present
microbi
surfac
includ
e
coli
klebisella
aerogen
neisseria
meningitid
staphylococcu
aureu
pneumonia
fumigatu
c
albican
cr
kerrigan
brown
howev
also
great
variat
bind
mbl
variou
organ
candida
albican
bhaemolyt
group
streptococci
staphylococcu
aureu
bind
high
affin
clostridium
sp
pseudomona
aeruginosa
staphylococcu
epidermidi
bhaemolyt
streptococci
streptococcu
pneumonia
exhibit
low
bind
santo
et
al
also
observ
organ
eg
klebsiella
sp
escherichia
coli
show
variabl
pattern
bind
later
shown
absenc
sialic
acid
lipooligosaccharid
lo
neisseria
meningitidi
serogroup
b
serogroup
c
neisseria
gonorrhoea
permit
mbl
bind
presenc
sialic
acid
lo
result
poor
mbl
bind
similar
studi
salmonella
sp
found
mbl
bind
rough
chemotyp
exhibit
low
bind
smooth
chemotyp
ambrosio
de
messiasreason
order
activ
complement
system
mbl
bind
target
exampl
mannos
surfac
bacterium
masp
protein
function
cleav
blood
protein
fragment
bind
surfac
bacterium
initi
format
convertas
subsequ
complement
cascad
catalyz
convertas
result
creat
membran
attack
complex
caus
lysi
pathogen
mbl
bound
worthley
et
al
worthley
et
al
fig
import
compon
innat
immun
act
anteantibodi
andor
diseas
modifi
mbl
thought
influenc
disord
divers
meningococc
diseas
rheumatoid
arthriti
cystic
fibrosi
recurr
miscarriag
vulvovagin
candidiasi
yeast
infect
vulva
vagina
million
women
suffer
vulvovagin
candidiasi
worldwid
women
bear
mbl
variant
allel
higher
risk
vulvovagin
candidiasi
syndrom
cervicovagin
lavag
cvl
mbl
level
gene
mutat
frequenc
higher
women
suffer
vulvovagin
candidiasi
control
liu
et
al
hand
mbl
level
low
ngml
women
recurr
vulvovagin
candidiasi
associ
high
gene
mutat
frequenc
compar
control
ngml
ip
lau
parenter
administr
mbl
increas
resist
pelli
et
al
autolog
function
mbl
perhap
perform
regulatori
role
within
immun
system
mbl
interact
human
peripher
blood
cell
b
lymphocyt
natur
killer
cell
mbl
capabl
bind
differ
glycosyl
ligand
sever
autolog
cell
type
via
carbohydraterecognit
domain
specul
could
function
signific
extravascular
site
perhap
individu
possess
mbl
genotyp
confer
mbl
suffici
down
et
al
down
et
al
nevertheless
mbl
genotyp
variou
popul
led
suggest
may
biolog
advantag
associ
absenc
protein
addit
protein
also
modul
diseas
sever
least
part
complex
dosedepend
influenc
cytokin
product
moreov
appear
genet
balanc
individu
gener
benefit
high
level
protein
find
suggest
concept
mbl
protein
involv
sole
first
line
defens
oversimplif
protein
rather
view
rang
activ
includ
diseas
modul
turner
hamva
dommett
et
al
worthley
et
al
mechan
signal
pathway
involv
process
remain
elucid
though
defici
mbl
associ
increas
suscept
infect
roo
et
al
indic
antibodymedi
classic
pathway
activ
compens
impair
target
opson
via
mbl
pathway
mbldefici
individu
lack
mbl
may
relev
context
coexist
secondari
immun
defici
replac
therapi
appear
promis
develop
recombin
product
permit
extens
mbl
therapi
random
clinic
trial
suffici
size
provid
clear
evid
physiolog
signific
intrigu
glycoprotein
mbl
attract
great
interest
potenti
candid
passiv
immunotherapi
prevent
infect
gupta
et
al
singl
point
mutat
exon
human
gene
appear
impair
gener
function
oligom
lead
secondari
structur
abnorm
collagen
tripl
helix
failur
form
biolog
function
higher
order
oligom
defici
function
protein
common
certain
popul
eg
subsaharan
africa
virtual
absent
other
eg
indigen
australian
increas
incid
infect
individu
mutat
associ
autoimmun
disord
sle
rheumatoid
arthriti
thu
mbl
potenti
candid
passiv
immunotherapi
prevent
infect
polymorph
mbl
gene
associ
exon
codon
concentr
mbl
plasma
determin
genet
primarili
genet
polymorph
first
exon
structur
gene
promot
region
gene
encod
mbl
pseudogen
locat
long
arm
chromosom
contain
four
exon
number
singl
nucleotid
polymorph
snp
character
gene
exon
harbour
three
missens
snp
give
rise
amino
acid
exchang
first
part
collagen
region
two
snp
gli
asp
name
b
gli
glu
name
c
exchang
glycin
acet
amino
acid
third
arg
cy
introduc
cystein
collagen
region
residu
number
includ
leader
sequenc
residu
fig
wild
type
denot
heterozyg
individu
b
c
mutat
substanti
decreas
mbl
serum
concentr
wherea
mbl
undetect
serum
homozyg
individu
three
structur
mutat
within
exon
codon
invari
refer
b
c
variant
addit
three
variant
structur
allel
promot
region
also
show
number
snp
well
influenc
express
mbl
three
snp
code
region
gene
associ
abnorm
polymer
mbl
molecul
decreas
serum
concentr
mbl
strongli
impair
function
mbl
snp
associ
increas
suscept
infect
especi
immunecompromis
person
well
acceler
progress
chronic
diseas
normal
serum
level
mbl
rang
ngml
healthi
caucasian
howev
wide
variat
occur
due
point
mutat
codon
exon
promotor
region
mbl
gene
turner
separ
point
mutat
collagen
domain
human
mbl
associ
immunedefici
caus
reduc
complement
activ
variant
mbl
well
lower
serum
mbl
concentr
mbl
defici
b
mutat
associ
caucasian
popul
steffensen
et
al
cohort
australian
blood
donor
mbl
promot
code
snp
genotyp
signific
associ
found
code
promot
polymorph
mbl
antigen
function
level
minchinton
et
al
point
mutat
exon
codon
promot
polymorph
bp
mbl
gene
associ
increas
suscept
variou
infecti
diseas
steffensen
et
al
roo
et
al
codon
mutat
frequent
british
caucasian
hong
kong
chines
popul
replac
aspart
acid
residu
disrupt
fifth
glyxaayaa
repeat
collagenlik
domain
kda
mbp
peptid
chain
prevent
format
normal
tripl
helix
sumiya
et
al
super
et
al
suggest
genotyp
occur
popul
encod
function
protein
super
et
al
also
suggest
gli
asp
allel
account
defici
state
instead
suggest
mbp
may
two
predomin
allel
form
overlap
function
differ
abil
activ
classic
pathway
complement
healthi
danish
individu
investig
homozyg
ggc
heterozyg
homozyg
gac
gene
frequenc
gac
allel
found
dna
sequenc
clone
exon
one
gac
homozyg
individu
reveal
substitut
median
mbp
concentr
group
contain
gac
allel
time
lower
ggc
homozyg
group
howev
rang
mbp
plasma
wide
overlap
group
mbp
protein
detect
gac
homozygot
studi
suggest
gac
allel
abl
produc
function
mbp
protein
may
detect
serum
low
concentr
gar
et
al
point
mutat
gga
gaa
involv
codon
exon
report
gambian
west
africa
gambian
codon
mutat
remark
common
wherea
codon
mutat
rare
contrast
codon
mutat
frequent
british
caucasian
hong
kong
chines
popul
predict
homozyg
heterozyg
individu
would
profoundli
reduc
serum
level
protein
confirm
immunoassay
complement
activ
lectin
pathway
two
mutat
arisen
independ
diverg
african
nonafrican
popul
codon
polymorph
increas
risk
prematur
deliveri
gene
polymorph
associ
increas
risk
neonat
infect
relat
matern
genotyp
risk
prematur
deliveri
indic
bodam
et
al
suggest
frequenc
codon
polymorph
higher
preterm
group
compar
term
group
vs
frequenc
codon
polymorph
equal
group
vs
data
suggest
fetal
genotyp
might
addit
genet
factor
contribut
risk
prematur
deliveri
untransl
region
posit
pq
variant
gene
three
base
substitut
exon
codon
b
c
result
aminoacid
chang
arginin
cystein
glycin
aspart
acid
glycin
glutam
acid
respect
decreas
level
function
mbl
normal
allel
name
proteas
reprint
permiss
macmillan
publish
ltd
gene
immun
gar
et
al
inflammatori
respons
syndrom
associ
increas
preval
posit
bacteri
cultur
sepsi
alter
preval
septic
shock
decreas
surviv
furthermor
snp
associ
gramneg
bacteria
tolllik
gramposit
bacteria
wherea
mbl
associ
particular
organ
class
preval
codon
mutat
mbl
gene
patient
repeat
respiratori
infect
well
preval
mbl
mutant
genotyp
among
patient
diffus
panbronchiol
support
gomi
et
al
mellitu
insulin
resist
featur
gestat
diabet
mellitu
gdm
genet
predisposit
proinflammatori
state
could
favor
appear
gdm
pregnanc
associ
found
gdm
gdm
patient
carri
mutat
requir
insulin
therapi
frequent
heavier
infant
gdm
women
homozyg
wildtyp
allel
invers
correl
gdm
patient
neonat
weight
plasma
mbl
level
report
thu
pregnant
women
bear
mbl
allel
greater
risk
develop
gdm
heavier
infant
megia
et
al
mbl
genotyp
acut
lymphoblast
leukemia
epidemiolog
studi
show
acut
lymphoblast
leukemia
induc
interact
immun
system
earli
childhood
infect
sinc
certain
type
childhood
acut
lymphoblast
leukemia
develop
multipl
step
process
involv
preand
postnat
genet
event
mbl
may
play
critic
role
immun
respons
earli
childhood
specif
immun
protect
develop
schmiegelow
et
al
indic
lowlevel
mbl
genotyp
associ
increas
risk
childhood
particularli
earli
age
onset
childhood
may
often
initi
utero
prenat
origin
childhood
leukemia
ascerten
children
bprecursor
acut
lymphoblast
leukemia
carri
chromosom
transloc
common
subtyp
childhood
studi
provid
evid
develop
bprecursor
may
initi
utero
howev
age
leukemia
may
invers
correl
burden
cell
leukemia
clonal
marker
ie
leukemia
predispos
cell
birth
hjalgrim
et
al
mbl
genotyp
viral
hepat
preval
mutat
mbl
gene
assess
patient
hepat
b
mutat
codon
mbp
gene
present
two
caucasian
patient
acut
hepat
b
nine
caucasian
patient
chronic
hepat
b
compar
four
caucasian
control
contrast
preval
mutat
similar
asian
patient
chronic
hepat
b
asian
control
one
vs
two
mutat
codon
codon
found
similar
proport
patient
control
find
show
caucasian
asian
patient
associ
codon
mutat
mbl
gene
persist
hepat
b
viru
hbv
infect
suggest
import
role
gene
gene
linkag
disequilibrium
mbl
determin
outcom
hbv
infect
adult
neonat
life
thoma
et
al
bellami
et
al
investig
associ
variant
mbp
allel
malaria
tuberculosi
hbv
adult
children
gambia
gambian
screen
mbp
mutat
homozyg
wildtyp
allel
carrier
singl
variant
allel
possess
mutant
allel
common
mutat
africansth
codon
variant
allel
weakli
associ
resist
tuberculosi
patient
control
although
mbp
defici
may
predispos
recurr
infect
studi
fail
provid
evid
defici
major
risk
factor
infecti
diseas
bellami
et
al
hepat
c
viru
hcv
envelop
glycoprotein
bind
dcsign
relat
liver
endotheli
cell
lectin
highmannos
nglycan
sever
highmannos
nglycan
structur
defin
cluster
bind
sever
subunit
oligomer
lectin
crd
repres
strategi
hcv
target
concentr
liver
infect
dendrit
cell
lozach
et
al
determin
relev
mbl
polymorph
hepat
c
viru
infect
matsushita
et
al
determin
mbl
genotyp
hepat
c
virusinfect
chronic
hepat
patient
healthi
control
japan
look
polymorph
loci
hl
xy
within
promot
region
pq
ab
within
mbl
gene
indic
mblrelat
innat
immun
system
play
import
role
elimin
hepat
c
viru
interferon
therapi
matsushita
et
al
matsushita
et
al
demonstr
mbl
genotyp
significantli
associ
increas
risk
primari
biliari
cirrhosi
pbc
increas
product
mbl
play
critic
role
immunopathogenesi
autoactiv
mutat
mbl
mutat
asp
gli
glu
disrupt
disulfidebond
arrang
protein
caus
least
fivefold
increas
halftim
secret
mbp
compar
wildtyp
rat
serum
mbp
similar
phenotyp
includ
threefold
increas
halftim
secret
disrupt
disulfid
bond
arrang
ineffici
complement
fixat
observ
nearbi
glucosylgalactosyl
hydroxylysin
residu
posit
replac
arginin
residu
result
suggest
defect
secret
result
structur
chang
collagenlik
domain
like
contributori
factor
mbp
immunodefici
heis
et
al
investig
molecular
defect
associ
heterozygos
rat
serum
mbp
polypeptid
mbpa
ident
sequenc
human
mbp
rat
mbp
polypeptid
contain
mutat
associ
human
immunodefici
coexpress
mammalian
express
system
result
protein
secret
almost
exclus
heterooligom
defect
activ
complement
cascad
function
defect
caus
structur
chang
ntermin
collagen
cysteinerich
domain
mbp
disrupt
interact
associ
serin
proteas
mutat
demonstr
snp
give
rise
molecular
defect
lead
diseas
phenotyp
heterozyg
individu
walli
walli
et
al
analyz
molecular
function
defect
associ
two
variant
protein
lectin
pathway
mutat
gli
asp
gli
glu
creat
compar
structur
chang
rat
mbl
variant
activ
complement
less
effici
variant
turn
approxim
sevenfold
lower
activ
wildtyp
mbl
analysi
mutant
complex
form
recombin
protein
show
reduc
complement
activ
mutant
mbl
due
failur
activ
effici
bind
mannanco
surfac
disrupt
interact
well
chang
oligomer
structur
reduc
bind
carbohydr
ligand
compar
wildtyp
mbl
probabl
account
intermedi
phenotyp
variant
howev
carbohydr
bind
activ
ostens
complet
decoupl
complex
assembl
mutant
rate
activ
greater
basal
rate
zymogen
autoactiv
analog
molecular
defect
human
mbl
probabl
combin
creat
mutant
phenotyp
immunodefici
individu
walli
et
al
sinc
difficult
evalu
mbl
patient
blood
basi
protein
content
combin
mbl
genotyp
due
possibl
associ
alter
oligomer
state
mbl
dumestreperard
et
al
purifi
mbl
human
plasma
show
presenc
mbl
two
differ
oligomer
form
data
specif
activ
form
show
higher
oligomer
form
mbl
abil
induc
cleavag
effici
correspond
lower
oligom
dumestreperard
et
al
defin
abnorm
mbl
pathway
diseas
associ
although
associ
mbl
defici
risk
infect
common
diseas
death
year
followup
establish
role
mbl
innat
immun
system
yet
larg
ethnic
homogen
caucasian
popul
evid
signific
differ
infecti
diseas
mortal
mbldefici
individu
versu
control
suggest
mbl
defici
major
risk
factor
morbid
death
adult
caucasian
popul
dahl
et
al
eisen
minchinton
kilpatrick
summerfield
et
al
address
possibl
correl
mbl
level
clinic
condit
issu
defin
mbl
defici
physiolog
relev
mbl
level
lead
clinic
manifest
like
differ
differ
diseas
exampl
given
number
differ
level
use
cutoff
valu
defin
mbl
defici
judg
clinic
trial
appear
least
ng
mblml
plasma
need
reconstitut
vitro
function
activ
deposit
mbl
infus
mbl
defici
individu
valdimarsson
et
al
hand
leukaem
patient
cutoff
level
ngml
suggest
peterslund
et
al
neth
et
al
case
obstetr
problem
even
lower
level
ngml
indic
broad
rang
protein
bind
highmannos
carbohydr
found
surfac
envelop
protein
hiv
thu
interfer
viral
life
cycl
provid
new
method
control
hiv
infect
glycosyl
hiv
provid
formid
barrier
develop
strong
antibodi
respons
viru
also
provid
potenti
site
attack
innat
immun
system
mblmbp
mbl
bind
hiv
depend
highmannos
glycan
present
host
cell
glycan
incorpor
virion
contribut
substanti
interact
mbl
shown
interact
test
hiv
strain
howev
drug
alter
process
carbohydr
enhanc
neutral
hiv
primari
isol
mbl
complement
activ
opson
hiv
due
mbl
bind
also
observ
immun
mechan
studi
detail
mbl
also
shown
block
interact
hiv
dcsign
clinic
studi
show
level
mbl
acutephas
protein
increas
hiv
diseas
appar
univers
reactiv
hiv
strain
mbl
clearli
repres
import
mechan
recognit
hiv
immun
system
howev
studi
need
defin
vivo
contribut
mbl
clearanc
destruct
hiv
boto
wlodaw
ji
et
al
mbl
bind
high
mannos
glycan
shown
neutral
cell
lineadapt
strain
hiv
iiib
hiv
primari
isol
pi
gener
resist
neutral
antibodi
consid
pi
produc
primari
cell
could
alter
number
high
mannos
glycan
hiv
rel
cell
line
ying
et
al
show
pi
cell
lineadapt
hiv
despit
bind
mbl
rel
resist
neutral
level
mbl
normal
present
serum
howev
bind
opson
hiv
mbl
may
alter
viru
traffick
viralantigen
present
hiv
infect
ying
et
al
search
effect
polymorph
suscept
progress
infect
children
dzwonek
et
al
observ
mbl
defici
frequent
patient
sever
diseas
studi
suggest
variant
may
less
frequent
children
classifi
longterm
nonprogressor
ltnp
henc
mbl
analysi
use
identifi
children
slow
diseas
progress
consequ
may
requir
immedi
antiretrovir
treatment
dzwonek
et
al
product
hiv
presenc
mannosidas
inhibitor
deoxymannojirimycin
dmm
significantli
enhanc
bind
hiv
mbl
increas
mbl
neutral
mtropic
hiv
primari
isol
contrast
hiv
cultur
presenc
alphaglucosidas
ii
inhibitor
castanospermin
deoxynojirimycin
show
slight
effect
viru
bind
neutral
mbl
studi
suggest
specif
alter
nlink
carbohydr
hiv
enhanc
mblmediat
neutral
viru
strengthen
interact
mbl
hart
et
al
respiratori
syncyti
viru
rsv
import
microbiolog
caus
lower
respiratori
tract
infect
lrti
infant
mbl
defici
common
immunodefici
african
contin
mbl
defici
impact
hospit
lrti
caus
rsv
infant
soweto
south
africa
contrari
expect
result
suggest
associ
low
level
mbl
carriag
variant
allel
lrti
caus
rsv
kristensen
et
al
littl
known
innat
immun
respons
sever
acut
respiratori
syndrom
sar
corona
viru
cov
infect
mbl
play
import
role
sarscov
infect
distribut
mbl
gene
polymorph
significantli
differ
patient
sar
normal
subject
higher
frequenc
haplotyp
associ
low
defici
serum
level
mbl
patient
sar
howev
associ
mbl
genotyp
associ
low
defici
serum
level
mbl
mortal
relat
sar
mbl
could
bind
sarscov
calciumdepend
mannaninhibit
fashion
vitro
suggest
bind
carbohydr
recognit
domain
mbl
furthermor
deposit
complement
sarscov
enhanc
mbl
inhibit
infect
sarscov
mbl
fetal
rhesu
kidney
cell
suggest
mbl
contribut
firstlin
host
defens
sarscov
mbl
defici
suscept
factor
acquisit
sar
ip
et
al
suscept
tcell
lymphotrop
viru
pont
et
al
investig
associ
mbl
gene
polymorph
suscept
human
tcell
lymphotrop
viru
htlv
infect
htlvinfect
asymptomat
subject
detect
mbl
mbl
b
mbl
c
perform
amplifi
fragment
bp
exon
restrict
fragment
length
polymorph
analysi
bani
mboii
endonucleas
strong
associ
demonstr
mbl
polymorph
htlv
infect
presenc
genotyp
bb
may
associ
suscept
htlv
though
studi
larger
number
individu
necessari
mbl
polymorph
could
possibl
impact
diseas
associ
htlv
infect
pont
et
al
studi
demonstr
bind
mbl
endothelium
caus
excess
complement
activ
subsequ
tissu
damag
known
jordan
et
al
mbl
defici
may
advantag
circumst
sinc
mbl
may
lead
increas
cytokin
secret
macrophag
takahashi
et
al
seem
delic
balanc
mbl
level
may
involv
harm
benefici
inflamm
cardiovascular
system
etiolog
autoimmun
diseas
larg
unknown
studi
associ
mbl
defici
rheumatoid
arthriti
ra
discuss
review
graudal
barton
et
al
result
depend
ethnic
group
type
patient
symptom
studi
low
level
serum
mbl
associ
higher
erythrocyt
sediment
rate
esr
joint
swell
score
limit
joint
motion
score
annual
increas
radiograph
destruct
score
despit
indic
low
mbl
level
may
link
symptom
indic
poor
prognosi
well
earlier
debut
whether
variant
allel
mbl
gene
caus
low
serum
concentr
mbl
associ
increas
suscept
ra
eros
outcom
incept
cohort
patient
earli
polyarthr
studi
jacobsen
et
al
jacobsen
et
al
suggest
mbl
variant
allel
appear
weak
suscept
marker
ra
patient
earli
polyarthr
homozyg
mbl
structur
variant
allel
higher
risk
develop
earli
eros
ra
find
togeth
posit
associ
mbl
variant
allel
increas
serum
level
igm
rf
crp
point
mbl
gene
relev
locu
pathophysiolog
ra
graudal
indic
mbldefici
patient
rel
risk
sever
radiograph
event
compar
mbl
compet
group
rel
risk
rr
earli
autoantibodi
posit
patient
develop
seriou
radiograph
joint
destruct
significantli
lower
autoantibodiesneg
patient
perhap
mbl
autoantibodi
predictor
prognosi
ra
play
import
role
pathogenesi
ra
graudal
lee
et
al
low
level
protein
relat
poor
prognosi
rheumatoid
arthriti
perhap
due
modulatori
action
mbl
exert
secret
tumor
necrosi
factor
central
molecul
pathogenesi
rheumatoid
arthriti
graudal
et
al
low
mbl
level
also
associ
adult
dermatomyos
probabl
relat
reduc
clearanc
apoptot
keratinocyt
werth
et
al
genotyp
relat
lower
product
mbl
also
link
develop
system
lupu
erythematosu
villarr
et
al
davi
et
al
genet
factor
play
major
role
develop
sle
case
famili
concord
rate
ident
twin
genet
studi
mice
suggest
complex
mechan
transmiss
involv
interact
among
sever
suscept
gene
probabl
protect
gene
genet
studi
human
identifi
nearli
chromosom
area
possibl
involv
lupu
transmiss
signific
linkag
found
least
six
region
two
chromosom
one
near
hla
region
chromosom
three
chromosom
respect
genet
polymorph
cytokin
perhap
tcell
receptor
tcr
may
contribut
deregul
lymphocyt
activ
polymorph
fc
receptor
immunoglobulin
may
affect
immun
complex
clearanc
therebi
promot
tissu
damag
genet
studi
need
enrich
fund
knowledg
lupu
identifi
new
target
treatment
perdrig
et
al
sever
investig
mbl
sle
consensu
emerg
low
level
mbl
predispos
develop
diseas
howev
connect
like
sle
develop
almost
rare
case
defici
rather
seem
mbl
defici
aggrav
diseas
develop
ohlenschlaeg
et
al
takahashi
et
al
sle
patient
mbl
defici
increas
risk
respiratori
tract
infect
gar
et
al
takahashi
et
al
well
risk
develop
arteri
thrombos
ohlenschlaeg
et
al
infecti
diseas
evid
risk
patholog
increas
anoth
coexist
immun
defect
exampl
cohort
spanish
patient
odd
ratio
develop
sle
individu
mbl
defici
increas
also
coexist
partial
defici
davi
et
al
studi
patient
sle
report
mbl
defici
also
influenc
risk
develop
certain
complic
includ
arteri
thrombos
ohlenschlaeg
et
al
respiratori
tract
infect
gar
et
al
takahashi
et
al
whether
dysfunct
defici
mbp
variant
found
increas
frequenc
black
patient
sle
determin
sullivan
et
al
two
structur
polymorph
mbp
associ
low
serum
level
mbp
found
significantli
increas
frequenc
sle
patient
popul
contrast
promot
haplotyp
associ
particularli
high
serum
level
mbp
neg
associ
sle
thu
seem
defici
mbp
predispos
individu
sle
sullivan
et
al
distribut
promot
variant
mbl
gene
correl
promot
variant
serum
mbl
concentr
chines
patient
sle
investig
signific
differ
distribut
two
pair
promot
polymorph
hl
yx
sle
patient
control
observ
analysi
correl
promot
haplotyp
serum
mbl
level
reveal
hy
highestproduc
ly
intermediateproduc
lx
lowestproduc
haplotyp
lx
haplotyp
present
frequenc
sle
patient
control
significantli
associ
sle
lowproduc
promot
polymorph
mbl
gene
associ
sle
low
serum
mbl
level
risk
factor
sle
ip
et
al
whether
occurr
characterist
progress
sle
associ
polymorph
mbl
gene
serum
mbl
concentr
takahashi
et
al
report
mbl
gene
polymorph
influenc
suscept
sle
direct
effect
diseas
characterist
serum
mbl
level
fluctuat
cours
sle
individu
patient
mbl
genotyp
may
use
assess
risk
infect
treatment
sle
mbl
fcgrii
polymorph
implic
candid
suscept
gene
sle
patient
carri
mbl
codon
mutant
allel
frequent
control
haplotyp
hy
significantli
lower
case
compar
control
mbl
gene
codon
mutant
allel
appear
risk
factor
sle
whilst
haplotyp
encod
high
level
mbl
protect
diseas
howev
differ
control
patient
signific
fcgriia
polymorph
consid
villarr
et
al
nephriti
sle
hypocomplementaemia
complement
deposit
describ
man
experiment
model
mice
mbl
express
two
form
mbla
mblc
young
old
mrllpr
control
mrl
declin
level
mbla
mblc
show
high
degre
correl
age
mrllpr
mice
autoimmun
pronounc
high
autoab
titer
strong
deposit
glomerular
immun
complex
associ
deposit
mbla
mblc
thu
addit
classic
pathway
altern
pathway
lectin
pathway
complement
activ
also
involv
murin
lupu
nephriti
sle
patient
associ
reduc
function
activ
mbl
pathway
complement
relat
express
mbl
variant
allel
increas
level
autoantibodi
cardiolipin
mbl
enhanc
product
autoantibodi
may
relat
disturb
clearanc
apoptot
materi
due
impair
mbl
function
cohort
mrllpr
mice
known
develop
agedepend
slelik
diseas
show
month
age
mice
alreadi
elev
level
autoantibodi
elut
kidney
confirm
presenc
antibodi
renal
immun
deposit
mrllpr
mice
control
mrl
mice
thu
antibodi
alreadi
present
serum
immun
deposit
kidney
earli
life
therefor
play
role
nephriti
experiment
slelik
diseas
mice
trouw
et
al
effect
armepavin
autoimmun
diseas
mrlmpjlprlpr
mice
armepavin
nelumbo
nucifera
suppress
cell
prolifer
armepavin
prevent
lymphadenopathi
elong
life
span
mrlmpjlprlpr
mice
diseas
featur
similar
human
sle
action
seem
mediat
inhibit
splenocyt
prolifer
suppress
ifng
gene
express
reduct
glomerular
hypercellular
immun
complex
deposit
decreas
urinari
protein
antidoubl
strand
dna
autoantibodi
product
suggest
armepavin
immunomodul
manag
autoimmun
diseas
like
sle
liu
et
al
sle
patient
associ
occurr
autoantibodi
mbl
renal
involv
presenc
autoantibodi
mbl
analog
autoantibodi
patient
sle
contribut
diseas
develop
antimbl
autoantibodi
igg
isotyp
bind
site
igg
antimbl
locat
f
ab
portion
antimbl
present
sera
sle
patient
influenc
function
activ
mbl
seelen
et
al
sle
patient
igg
antimbl
antibodi
normal
control
howev
sle
antibodi
neither
sensit
specif
condit
occur
frequent
prolif
lupu
nephriti
particularli
activ
diseas
furthermor
level
rise
mani
case
prior
relaps
lupu
nephriti
suggest
pathogen
role
autoantibodi
immun
complexmedi
renal
diseas
addit
may
interfer
clearanc
apoptot
cell
influenc
induct
express
autoimmun
kallenberg
mok
et
al
cardiovascular
diseas
sle
cardiovascular
diseas
import
complic
patient
sle
variant
allel
mbl
gene
associ
sle
well
sever
atherosclerosi
ohlenschlaeg
et
al
determin
whether
mbl
variant
allel
associ
increas
risk
arteri
thrombosi
among
danish
patient
sle
suggest
among
patient
sle
homozygos
mbl
variant
allel
associ
increas
risk
arteri
thrombosi
risk
venou
thrombosi
increas
indic
mbl
specif
role
provid
protect
arteri
thrombosi
ohlenschlaeg
et
al
system
inflammatori
respons
syndrom
sir
well
known
patient
major
surgeri
bone
clinic
studi
critic
ill
patient
requir
intens
care
manag
shown
individu
mbl
defici
like
develop
sir
progress
septic
shock
death
gar
et
al
fidler
et
al
find
may
well
relat
proinflammatori
cytokin
respons
case
sir
occur
respons
infect
sepsi
use
describ
symptom
sever
septic
shock
may
develop
multiorgan
dysfunct
mod
mbl
level
genotyp
investig
adult
sepsi
prospect
admit
icu
differ
seen
genotyp
frequenc
patient
sir
compar
healthi
control
frequenc
mbl
variant
genotyp
significantli
higher
patient
sepsi
compar
patient
without
sepsi
risk
ratio
develop
sever
sepsi
septic
shock
rang
time
higher
patient
ao
oo
versu
aa
genotyp
mbl
level
invers
relat
sever
sepsi
gar
et
al
b
snp
mbl
clinic
phenotyp
critic
ill
caucasian
sir
associ
increas
preval
posit
bacteri
cultur
admiss
icu
patient
low
mbl
haplotyp
group
significantli
increas
rate
sepsi
septic
shock
admiss
icu
surviv
day
differ
significantli
low
mbl
haplotyp
high
mbl
haplotyp
group
furthermor
mbl
associ
particular
organ
class
preval
codon
mutat
mbl
gene
patient
repeat
respiratori
infect
well
preval
mbl
mutant
genotyp
among
patient
diffus
panbronchiol
support
gomi
et
al
contrast
preval
mbl
mutant
genotyp
among
patient
nontubercul
mycobacteria
aspergillu
chronic
infect
differ
control
subject
thu
snp
innat
immun
receptor
may
alter
recognit
clearanc
bacteria
without
chang
outcom
critic
ill
adult
system
inflammatori
respons
syndrom
sutherland
et
al
polymorph
codon
allel
promot
variant
mannos
mbl
gene
patient
primari
sjogren
syndrom
ss
suggest
one
genet
factor
determin
suscept
ss
wang
et
al
fidler
et
al
analyz
mbl
level
genotyp
level
critic
ill
children
admit
icu
sevenfold
greater
risk
develop
sir
within
h
admiss
patient
observ
carri
mbl
variant
allel
wild
type
allel
ao
oo
vs
aa
signific
relat
also
found
sever
system
respons
infect
presenc
mbl
mutat
sever
ill
among
patient
admit
infect
divid
local
infect
sepsi
septic
shock
median
mbl
level
invers
relat
sever
children
mbl
level
ngml
greater
chanc
develop
sir
studi
frequenc
sepsi
low
birth
weight
infant
reveal
statist
signific
clinic
data
infant
without
specif
mutat
number
gene
includ
mbl
genotyp
ahren
et
al
follow
surgeri
patient
undergo
major
elect
gastrointestin
surgeri
malign
diseas
siassi
et
al
report
patient
develop
sepsi
sir
show
significantli
lower
mean
postop
mbl
level
colorect
cancer
patient
postop
infect
associ
poor
prognosi
ytting
et
al
report
significantli
increas
frequenc
pneumonia
primari
oper
colorect
carcinoma
patient
low
mbl
level
mbl
defici
appear
play
import
role
suscept
critic
ill
patient
develop
progress
sepsi
septic
shock
confer
substanti
increas
risk
fatal
outcom
clearli
need
improv
defin
patient
group
clinic
data
relev
examin
inflammatori
bowel
diseas
ibd
patholog
spectrum
encompass
ulcer
coliti
uc
crohn
diseas
cd
indetermin
coliti
result
ibd
phenotyp
consequ
multipl
interact
environment
factor
particularli
enter
flora
host
respons
environ
determin
immunogenet
epitheli
nonimmun
genet
factor
mbl
import
compon
innat
immun
engend
consider
research
interest
earli
studi
unrel
patient
ibd
genotyp
exon
code
mutat
frequenc
defici
allel
significantli
lower
patient
uc
either
control
group
cd
rector
et
al
studi
rector
et
al
suggest
mbl
defici
could
protect
uc
altern
could
interpret
mbl
defici
individu
otherwis
predispos
ibd
may
skew
phenotyp
away
uc
spectrum
diseas
toward
cd
concept
support
anoth
studi
genotyp
patient
cd
uc
healthi
control
seibold
et
al
studi
also
assess
antisaccharomyc
cerevisia
antibodi
asca
mbl
level
within
subset
patient
albeit
slightli
differ
number
within
group
cd
patient
mbl
defici
significantli
like
posit
asca
lymphocyt
prolifer
respons
mannan
thu
appear
mbl
defici
could
impair
normal
process
mannanexpress
microbi
antigen
found
cell
surfac
mani
common
microorgan
accumul
antigen
could
stimul
immun
system
contribut
product
asca
possibl
pathogenesi
crohn
diseas
thu
mbl
defici
might
act
primarili
influenc
ibdspecif
phenotyp
patient
note
howev
followup
studi
test
larger
cohort
cd
patient
n
fail
confirm
signific
associ
variant
mbl
genotyp
asca
posit
joossen
et
al
seibold
et
al
suggest
frequenc
homozyg
compound
heterozyg
variant
exon
allel
differ
significantli
patient
suffer
cd
uc
healthi
control
celiac
diseas
multifactorialautoimmun
disord
caus
genet
suscept
patient
ingest
dietari
gluten
though
littl
known
genet
factor
strong
associ
two
hla
haplotyp
diseas
boniotto
et
al
indic
associ
celiac
diseas
presenc
variant
mbl
allel
boniotto
et
al
iltanen
et
al
report
frequenc
homozygos
variant
mbl
allel
higher
patient
among
italian
celiac
patient
show
presenc
allel
genotyp
frequenc
vari
significantli
celiac
patient
healthi
human
like
rare
case
celiac
diseas
neg
nonhla
suscept
genotyp
would
exert
greater
effect
studi
also
analyz
apoptosi
within
small
intestin
biopsi
specimen
show
mbl
tend
aggreg
area
apoptosi
within
epithelium
mbl
implic
normal
clearanc
apoptot
bodi
nauta
et
al
ogden
et
al
author
postul
associ
mbl
celiac
diseas
inde
autoimmun
condit
could
relat
impair
apoptosi
wherebi
mbl
defici
impair
normal
remov
clearanc
apoptot
cell
may
subsequ
reveal
previous
hidden
selfantigen
caus
loss
selftoler
spread
autoimmun
boniotto
et
al
associ
variant
allel
coeliac
diseas
also
confirm
within
finnish
popul
iltanen
et
al
worthley
et
al
low
mbl
genotyp
strongli
associ
celiac
diseas
symptom
well
increas
frequenc
secondari
autoimmun
diseas
immunohistochemistri
mbl
found
present
togeth
apoptot
cell
basal
lamina
intestin
epithelium
previous
found
mrna
mbl
boniotto
et
al
suggest
impair
remov
apoptot
cell
due
mbl
defici
might
predispos
develop
autoimmun
symptom
mice
lack
mbl
shown
less
effici
remov
apoptot
cell
stuart
et
al
vitro
studi
also
implic
mbl
remov
apoptot
cell
ogden
et
al
nauta
et
al
altern
explan
could
increas
suscept
intestin
infect
diarrhea
associ
low
mbl
may
chang
intestin
epithelia
thu
allow
abnorm
stimul
antigliadin
immun
respons
trigger
cascad
lead
celiac
diseas
role
mbl
like
celiac
diseas
could
easili
appli
autoimmun
disord
despit
wellestablish
role
mbl
innat
immun
rel
studi
describ
clinic
effect
mbl
defici
enter
infect
one
notabl
except
associ
mbl
defici
risk
cryptosporidium
parvum
enter
studi
indic
patient
biallel
code
mutat
oo
significantli
greater
chanc
cryptosporidiosi
compar
either
wildtyp
heterozyg
mutat
kelli
et
al
associ
mbl
defici
cryptosporidiosi
confirm
young
haitian
children
kirkpatrick
et
al
howev
two
combin
studi
present
compel
evid
role
mbl
host
defens
cryptosporidium
spp
infect
howev
mbl
defici
associ
increas
risk
escherichia
coli
coliti
complic
hu
proulx
et
al
h
pylori
one
common
human
bacteri
infect
affect
approxim
human
sever
immunogenet
polymorph
associ
clinic
outcom
h
pylori
infect
well
risk
infect
h
pylori
activ
mbl
vitro
cr
worthley
et
al
studi
demonstr
h
pylorirel
chronic
gastriti
caus
increas
gastric
mucos
mbl
express
associ
found
genotyp
risk
chronic
gastriti
bakromaniszyn
et
al
worthley
et
al
mbl
implic
mediat
gastrointestin
ischemiareperfus
injuri
mice
hart
et
al
mblnull
mice
defici
murin
gene
encod
mbl
develop
minor
gut
injuri
induc
ischemiareperfus
insult
compar
wildtyp
mice
contrari
mbl
implic
mediat
ischemia
reperfus
injuri
myocardium
walsh
et
al
kidney
kristensen
et
al
wherea
mbl
defici
associ
rheumat
disord
high
mbl
level
associ
diseas
report
hansen
et
al
rheumat
fever
rf
common
caus
acquir
valvular
diseas
children
young
adult
pathogen
mechan
respons
develop
rfrhd
associ
abnorm
host
immun
respons
humor
cellular
level
crossreact
streptococc
antigen
significantli
elev
circul
mbl
level
patient
rhd
togeth
greater
preval
mbl
defici
control
suggest
mbl
may
caus
undesir
complement
activ
contribut
pathogenesi
rhd
schafranski
et
al
probabl
mbl
defici
may
repres
advantag
develop
rheumat
mitral
stenosi
increas
mbl
level
may
relat
develop
rhd
normal
condit
mbl
bind
organ
tissu
situat
cellular
hypoxia
glycosyl
cell
surfac
may
occur
lead
deposit
mbl
follow
complement
activ
significantli
elev
level
mbl
observ
chronic
rhd
suggest
mbl
may
repres
pathogen
factor
complex
physiopatholog
diseas
wherea
mbl
defici
individu
might
less
suscept
develop
chronic
rhd
studi
demonstr
bind
mbl
endothelium
caus
excess
complement
activ
subsequ
tissu
damag
known
jordan
et
al
mbl
defici
may
advantag
circumst
sinc
mbl
may
lead
increas
cytokin
secret
macrophag
takahashi
et
al
condit
mbl
associ
diseas
sever
infecti
autoimmun
diseas
gar
et
al
gar
et
al
although
mbl
acutephas
protein
produc
liver
level
show
moder
increas
determin
genet
inflammatori
diseas
elev
mbl
level
patient
chronic
rhd
might
corrobor
chronic
inflammatori
activ
present
individu
contribut
valv
injuri
complement
activ
addit
mbl
may
act
immunomodulatori
molecul
induc
higher
secret
cytokin
macrophag
turner
hamva
seem
delic
balanc
mbl
level
may
involv
harm
benefici
inflamm
cardiovascular
system
exampl
kawasaki
diseas
system
vascul
childhood
possibl
caus
infect
develop
world
kawasaki
diseas
common
caus
acquir
heart
diseas
children
royl
et
al
mbl
initi
inflamm
biezeveld
et
al
studi
frequenc
mbl
genotyp
kawasaki
diseas
dutch
patient
found
higher
frequenc
mbl
mutat
compar
genotyp
control
children
younger
year
higher
risk
develop
cad
kawasaki
diseas
occur
frequent
orient
children
time
frequent
caucasian
royl
et
al
chines
cheung
et
al
see
differ
mbl
genotyp
patient
control
recent
observ
associ
human
coronaviru
kawasaki
diseas
esper
et
al
fit
mani
indic
mbl
antivir
activ
plaqu
materi
may
remov
insid
carotid
arteri
eg
endarterectomi
avoid
cerebr
attack
rugonfalvikiss
et
al
indic
femal
patient
genotyp
associ
lower
mbl
level
slower
rate
earli
restenosi
suggest
high
level
mbl
may
part
pathophysiolog
condit
studi
patient
sever
atherosclerosi
madsen
et
al
found
patient
myocardi
infarct
among
norwegian
low
mbl
allotyp
control
saevarsdottir
et
al
found
cohort
studi
iceland
risk
develop
myocardi
infarct
higher
mbl
defici
individu
relationship
marker
innat
immun
clinic
outcom
patient
heart
failur
hf
acut
myocardi
infarct
ami
suggest
atherogenesi
heart
failur
associ
alter
control
inflamm
innat
immun
defens
includ
tlr
mbl
circul
level
mbl
may
reflect
differ
aspect
innat
immun
respons
involv
innat
immun
respons
pathogenesi
postmi
heart
failur
ueland
et
al
mbl
play
dual
role
modifi
inflammatori
respons
steril
infecti
injuri
although
complement
wide
accept
particip
pathophysiolog
ischemiareperfus
injuri
specif
role
lectin
pathway
address
jordan
et
al
sinc
blockad
lectin
pathway
inhibitori
mab
protect
heart
ischemiareperfus
reduc
neutrophil
infiltr
attenu
proinflammatori
gene
express
appear
lectin
complement
pathway
activ
myocardi
ischemiareperfus
lead
tissu
injuri
mice
devoid
mbldepend
lectin
pathway
activ
fulli
activ
altern
classic
complement
pathway
protect
cardiac
reperfus
injuri
result
preserv
cardiac
function
significantli
mice
lack
major
compon
classic
complement
pathway
initi
complex
intact
mbl
complement
pathway
protect
injuri
thu
mbldepend
pathway
complement
activ
key
regul
myocardi
reperfus
ischem
injuri
walsh
et
al
diabet
patient
high
risk
diabeticnephropathi
whether
lectin
pathway
complement
activ
play
role
pathogenesi
human
glomerulonephr
well
known
propos
mbl
may
bind
alter
self
compon
may
possibl
found
diabet
patient
mbl
could
thu
potenti
pathogen
factor
diabet
cardiovascular
complic
eg
nephropathi
saevarsdottir
et
al
normoalbuminur
type
diabet
found
higher
mbl
level
nondiabet
control
stepwis
increas
circul
mbl
level
increas
level
urinari
albumin
excret
hansen
et
al
anoth
studi
significantli
larger
proport
patient
diabet
nephropathi
present
mbl
genotyp
associ
higher
mbl
level
compar
group
mbl
genotyp
associ
low
mbl
level
elev
serum
mbl
level
type
diabet
patient
diabet
nephropathi
confirm
saraheimo
et
al
long
follow
studi
type
diabet
patient
found
patient
type
diabet
mbllevel
median
mgml
risk
develop
micro
macroalbuminuria
patient
mbllevel
median
risk
develop
micro
macroalbuminuria
hovind
et
al
studi
suggest
high
mbl
genoand
phenotyp
associ
increas
risk
develop
diabet
kidney
diseas
assess
mbl
statu
may
prove
benefici
identifi
patient
risk
microand
macrovascular
complic
cr
thiel
et
al
mbl
detect
glomeruli
patient
lupu
nephropathi
membran
nephropathi
membranoprolif
glomerulonephr
type
antigbm
nephriti
propos
mbl
bind
agalactosyl
oligosaccharid
igg
termin
nacetylglucosamin
lhotta
et
al
elev
serum
mbl
level
implic
pathogenesi
renal
manifest
onlein
purpura
endo
et
al
iga
nephropathi
endo
et
al
form
human
glomerulonephr
lhotta
et
al
vascular
complic
diabet
mellitu
type
hansen
et
al
sarcoidosi
chronic
granulomat
diseas
unknown
aetiolog
caus
agent
may
infecti
microorgan
mbl
variant
predispos
sarcoidosi
increas
suscept
microorgan
among
sarcoidosi
patient
show
frequenc
variant
similar
regardless
sever
diseas
outcom
mbl
gene
variant
indic
influenc
suscept
sarcoidosi
age
diseas
onset
sever
diseas
averag
patient
age
time
diagnosi
similar
mbl
genotyp
foley
et
al
howev
woman
patient
pulmonari
sarcoidosi
suggest
interstiti
nephriti
without
proteinuria
hematuria
wherea
renal
biopsi
show
granulomat
interstiti
nephriti
mild
mesangi
prolif
glomerulonephr
case
renal
sarcoidosi
hypothes
p
acn
might
involv
pathogenesi
granulomat
interstiti
nephriti
play
role
glomerular
complement
activ
via
lectin
pathway
hagiwara
et
al
behcet
diseas
bd
multisystem
recurr
inflammatori
diseas
caus
combin
genet
environment
factor
haplotyp
gene
influenc
therapeut
respons
bd
thu
affect
clinic
symptom
bd
patient
promot
region
c
c
homozygot
found
lower
frequenc
bd
patient
control
differ
observ
allel
frequenc
c
yx
c
pq
ab
gene
bd
patient
control
hypa
haplotyp
contribut
bd
occurr
wherea
lypa
haplotyp
neg
associ
bd
bd
patient
sever
symptom
earlier
diseaseonset
age
higher
hypa
haplotyp
frequenc
bd
patient
show
poor
respons
therapi
higher
hypa
frequenc
show
good
respons
appear
possess
hypa
increas
risk
bd
hypa
haplotyp
play
role
mbl
level
increas
suscept
bd
park
et
al
mbl
defici
associ
poor
outcom
cystic
fibrosi
cf
lung
diseas
mutat
higher
serum
level
mbl
healthi
control
belong
mbl
pathway
serum
describ
thu
mbl
pathway
function
affect
mbl
genotyp
carlsson
et
al
patient
undergo
abdomin
aortic
aneurysm
aaa
repair
expos
ischaemiareperfus
injuri
iri
part
mediat
complement
activ
iri
patient
undergo
aaa
repair
experi
mean
decreas
plasma
mbl
level
repres
signific
lectin
pathway
activ
indic
consumpt
mbl
occur
aaa
repair
suggest
import
role
lectin
pathway
iri
henc
specif
transient
inhibit
lectin
pathway
activ
signific
therapeut
valu
patient
undergo
open
surgic
aaa
repair
norwood
et
al
guillainbarr
syndrom
gb
complement
activ
play
crucial
role
induct
extent
postinfecti
immunemedi
peripher
nerv
damag
genotyp
serum
mbl
level
mbl
complex
activ
associ
develop
sever
gb
b
allel
associ
function
defici
rel
mild
weak
studi
support
hypothesi
complement
activ
mediat
mbl
contribut
extent
nerv
damag
gb
codetermin
haplotyp
geleijn
et
al
periton
common
major
complic
treatment
modal
periton
dialysi
pd
uraem
patient
contribut
differ
complement
activ
pathway
studi
host
defens
experiment
polymicrobi
periton
induc
cecal
ligat
punctur
use
mice
defici
either
factor
b
mice
lack
classic
complement
activ
pathway
mice
defici
factor
b
lack
complement
activ
via
classic
altern
lectin
pathway
exhibit
maximum
mortal
indic
signific
contribut
lectin
altern
pathway
complement
activ
surviv
windbichl
et
al
examin
role
serum
mbl
concentr
point
mutat
mbl
gene
pdrelat
periton
lam
et
al
found
homozyg
heterozyg
patient
profoundli
reduc
serum
level
mbl
thu
dialysi
patient
lower
mbl
level
may
increas
suscept
infect
mbl
replac
therapi
follow
stem
cell
transplant
lifethreaten
complic
graft
versu
host
diseas
infect
remain
major
barrier
success
allogen
hemopoiet
stem
cell
transplant
sct
among
variou
factor
mbl
defici
risk
factor
infect
situat
immun
compromis
code
mutat
associ
increas
risk
major
infect
follow
transplant
promot
variant
also
associ
major
infect
highproduc
haplotyp
hya
associ
markedli
reduc
risk
infect
donor
code
mutat
recipi
hya
haplotyp
independ
associ
infect
multivari
analysi
thu
result
suggest
genotyp
influenc
risk
infect
follow
allogen
sct
donor
recipi
genotyp
import
mullighan
et
al
retrospect
studi
examin
associ
polymorph
gene
encod
mbl
risk
major
infect
postsct
conduct
relat
myeloabl
transplant
studi
show
lowproduc
code
allel
present
donor
significantli
associ
increas
risk
major
infect
recipi
follow
neutrophil
count
recoveri
furthermor
highproduc
haplotyp
hya
present
recipi
protect
infect
sinc
mbl
develop
therapeut
agent
find
suggest
administr
mbl
may
reduc
risk
infect
posttranspl
work
requir
confirm
result
result
indic
report
genet
determin
risk
infect
postsct
highlight
import
nonhla
genet
factor
determin
risk
transplant
complic
mullighan
bardi
genet
mbl
variant
frequent
associ
low
mbl
serum
level
higher
mbl
level
may
associ
complementmedi
damag
result
inferior
graft
surviv
berger
et
al
show
signific
differ
incid
delay
graft
function
recipi
low
mbl
level
ngml
compar
higher
mbl
level
ngml
data
confirm
pretranspl
mbl
level
may
provid
addit
inform
risk
stratif
prior
kidney
transplant
berger
et
al
complement
activ
harm
allograft
endothelium
heart
transplant
recipi
fian
et
al
record
transplantassoci
coronari
arteri
diseas
observ
associ
mbl
defici
also
record
acut
reject
transplant
seen
mbl
defici
compar
higher
mbl
level
assum
mbl
may
interact
transplant
tissu
initi
complement
activ
studi
ad
list
studi
suggest
complement
activ
harm
endothelium
gener
possibl
allograft
endothelium
particular
simultan
pancreaskidney
transplant
spkt
treatment
choic
patient
type
diabet
renal
failur
howev
procedur
character
high
rate
postop
infect
acut
reject
episod
cardiovascular
mortal
lectin
pathway
complement
activ
contribut
cardiovascular
diseas
diabet
may
play
import
role
inflammatori
damag
organ
transplant
mbl
serum
level
mbl
genotyp
patient
receiv
spkt
relat
graft
surviv
reveal
surviv
significantli
better
recipi
mbl
gene
polymorph
associ
low
mbl
level
thu
mbl
potenti
risk
factor
graft
patient
surviv
spkt
hypothes
mbl
contribut
pathogenesi
inflammationinduc
vascular
damag
transplant
organ
recipi
nativ
blood
vessel
berger
et
al
address
role
mbl
defici
verschuren
et
al
show
high
level
serum
mbl
associ
protect
urinari
tract
infect
specif
urosepsi
spkt
result
indic
import
role
lectin
pathway
complement
activ
antimicrobi
defens
transplant
recipi
verschuren
et
al
paediatr
oncolog
patient
febril
neutropenia
mbl
level
correl
clinic
laboratori
paramet
structur
mutat
lx
promot
polymorph
relat
defici
mbl
level
capac
increas
mbl
concentr
febril
neutropenia
associ
genotyp
infecti
paramet
differ
mbldefici
mblsuffici
neutropen
children
howev
patient
sever
neutropen
compromis
opsonophagocyt
effector
function
mbl
mbl
substitut
might
still
benefici
patient
phagocyt
activ
frak
et
al
five
polymorph
promot
first
exon
gene
alter
express
function
mbl
human
associ
inflammationrel
diseas
suscept
five
polymorph
creat
six
wellcharacter
haplotyp
result
lower
ie
lyb
lyc
hyd
lxa
higher
ie
hya
lya
serum
mbl
concentr
statist
signific
associ
found
x
allel
promot
yx
polymorph
result
lower
serum
mbl
concentr
improv
lung
cancer
surviv
among
white
patient
among
african
american
patient
function
yx
polymorph
innateimmun
gene
haplotyp
diplotyp
appear
associ
lung
cancer
surviv
among
white
patient
pine
et
al
significantli
higher
incid
mbl
deficiencyinsufficiencyassoci
genotyp
found
among
patient
malign
diseas
find
reflect
antitumorigen
activ
mbl
protein
suggest
potenti
therapeut
applic
howev
exclud
mutant
allel
may
linkag
disequilibrium
unidentifi
tumor
suscept
gene
swierzko
et
al
genet
variat
key
gene
could
influenc
risk
breast
cancer
preliminari
analysi
snp
breast
cancer
africanamerican
aa
patient
vs
control
caucasian
cau
patient
vs
control
present
evid
common
genet
variant
utr
might
influenc
risk
breast
cancer
aa
women
probabl
interact
secretor
haplotyp
associ
high
concentr
mbl
bernig
et
al
chang
cell
surfac
structur
oncogen
transform
appear
promot
bind
mbl
cancer
cell
hakomori
protein
mediat
cytotox
effect
includ
mbldepend
cell
mediat
cytotox
et
al
nakagawa
et
al
experiment
studi
suggest
mbl
wildtyp
mutant
b
allel
may
possess
anticolorect
cancer
tumor
activ
et
al
mbpmbl
bind
specif
oligosaccharid
express
surfac
human
colorect
carcinoma
cell
mbl
bind
occur
colon
adenocarcinoma
cell
line
leukem
cell
line
bind
mbl
cell
line
sugarspecif
calciumdepend
degre
mbl
bind
correl
express
lewi
lewi
b
antigen
cell
line
muto
et
al
intratumor
administr
recombin
vaccinia
viru
carri
gene
significantli
reduc
tumor
size
compar
control
along
prolong
surviv
mice
et
al
howev
result
reflect
clinic
trial
fact
patient
colorect
cancer
increas
activ
lectincompl
pathway
increas
level
serum
mbl
ytting
et
al
patient
undergo
surgeri
colorect
cancer
howev
low
preoper
level
serum
mbl
link
increas
risk
develop
postcolectomi
pneumonia
ytting
et
al
studi
may
clarifi
role
lectincompl
pathway
colorect
cancer
secondari
immunodefici
due
diseas
treatment
provid
interest
patient
popul
within
studi
role
mbl
one
group
compris
receiv
chemotherapi
malign
patient
chemotherapi
induc
neutropenia
increas
risk
infect
studi
thu
attempt
analyz
correl
mbl
defici
infect
patient
difficult
compar
studi
sinc
studi
includ
patient
varieti
underli
malign
varieti
chemotherapi
differ
combin
antimicrobi
agent
variou
factor
klein
kilpatrick
howev
clear
evid
import
mbl
protect
leukemia
patient
mbl
genotyp
mbl
level
correl
caus
frequenc
durat
febril
neutropen
period
children
receiv
chemotherapi
neth
et
al
major
children
patient
acut
lymphoblast
leukemia
children
variant
mbl
allel
exhibit
twice
mani
day
febril
neutropenia
children
wild
type
genotyp
analysi
mbl
quantif
support
children
less
mg
mblml
higher
number
day
febril
neutropenia
peterslund
et
al
describ
infect
defin
bacteremia
pneumonia
hematolog
malign
adult
treat
chemotherapi
patient
infect
except
one
show
mbl
level
mgml
vekeman
et
al
conduct
prospect
observ
studi
focus
assess
mbl
risk
factor
infect
chemotherapi
induc
neutropenia
adult
hematolog
cancer
patient
includ
patient
determin
mbl
level
well
mbl
genotyp
higher
rate
sever
infect
seen
mbl
defici
patient
impact
increas
acut
leukaem
patient
exclud
contrast
studi
bergmann
et
al
follow
adult
undergo
therapi
acut
myeloid
leukaemia
aml
involv
intens
highli
myelosuppress
treatment
found
effect
mbl
defici
frequenc
sever
durat
fever
suggest
sever
immunosuppress
induc
combin
myeloid
cancer
chemotherapi
may
obscur
normal
effector
function
mbl
though
kilpatrick
et
al
fail
see
anyth
modest
effect
mbl
level
ngml
retrospect
studi
patient
prepar
bone
marrow
transfer
half
present
aml
result
cast
doubt
potenti
valu
mbl
replac
therapi
clinic
context
grow
bodi
evid
indic
genet
factor
involv
increas
risk
infect
mbl
gene
polymorph
caus
low
level
mbl
associ
occurr
major
infect
patient
mainli
bear
hematolog
malign
highdos
chemotherapi
hdt
rescu
autolog
peripher
blood
stem
cell
transplant
autopbsct
retrospect
examin
patient
treat
hdt
autopbsct
reveal
lowproduc
genotyp
bb
blxa
associ
major
bacteri
infect
nationwid
studi
conduct
assess
allel
frequenc
mbl
code
mutat
total
healthi
individu
japan
reveal
frequenc
allel
b
almost
seven
differ
area
japan
common
occurr
suggest
mbl
defici
may
play
import
role
clinic
set
immunesuppress
horiuchi
et
al
studi
aittoniemi
et
al
patient
chronic
lymphocyt
leukemia
observ
effect
mbl
infect
possibl
associ
mbl
genotyp
sever
infect
patient
multipl
myeloma
receiv
moder
strength
induct
chemotherapi
studi
mbp
genotyp
identifi
bone
marrow
biopsi
studi
conclud
induct
chemotherapi
patient
multipl
myeloma
gener
protect
effect
wildtyp
chemotherapyrel
infect
appar
howev
indic
reduc
occurr
septicaemia
patient
wildtyp
compar
variant
studi
larger
cohort
patient
relev
moll
et
al
thu
studi
requir
describ
patient
particularli
risk
mbl
defici
mbl
knockout
mice
made
possibl
experiment
investig
effect
mbl
defici
mous
two
gene
encod
differ
mbl
molecul
mbla
c
compar
one
human
mbl
mice
abl
bind
carbohydr
surfac
activ
complement
system
slight
differ
carbohydr
specif
report
two
mous
mbl
mice
mbla
knockedout
first
produc
mice
mbla
c
knock
differ
seen
bacteria
inject
intraperiton
howev
mice
treat
cyclophosphamid
simul
chemotherapyinduc
neutropenia
intra
periton
infect
mbl
dko
abscess
wild
type
mbl
dko
mice
also
suscept
challeng
herp
simplex
viru
type
gadjeva
et
al
line
suggest
involv
mbl
autoimmun
diseas
mbl
dko
mice
examin
autoimmun
symptom
stuart
et
al
sign
observ
hand
abil
clear
apoptot
cell
less
effici
mbl
knockout
hypothes
mbl
bind
significantli
healthi
tissu
chang
due
abnorm
condit
might
reveal
mbl
ligand
inde
mbl
express
tumor
cell
line
gene
therapi
mblvaccinia
construct
found
protect
nude
mice
transplant
human
colorect
cancer
cell
line
et
al
vitro
studi
indic
bind
mbl
cell
expos
hypoxiareoxygen
simul
ischemiareperfus
subsequ
shown
infus
block
antimbl
antibodi
would
protect
myocardi
destruct
follow
ischemiareperfus
rat
model
jordan
et
al
use
mbl
dko
mice
kristensen
et
al
found
model
kidney
ischemia
reperfus
ir
injuri
mbl
dko
partial
protect
evidenc
better
kidney
function
mice
ischemiareperfus
increas
deposit
complement
factor
seen
wild
type
mice
bind
mbl
section
kidney
could
inhibit
mannos
agreement
devri
et
al
found
mbla
c
deposit
kidney
ischemiareperfus
mbl
wild
type
mice
recombin
vaccinia
viru
carri
human
mbp
gene
possess
potent
growthinhibit
activ
human
colorect
carcinoma
cell
transplant
ksn
nude
mice
treatment
result
prolong
life
span
tumorbear
mice
local
product
mbp
cytotox
activ
propos
mbp
depend
cellmedi
cytotox
mdcc
studi
offer
model
develop
effect
specif
host
defens
factor
cancer
gene
therapi
et
al
thiel
et
al
sinc
genet
determin
mbl
defici
common
associ
increas
suscept
varieti
infect
potenti
benefit
mbl
reconstitut
therapi
need
evalu
phase
trial
mbldefici
healthi
adult
volunt
receiv
total
mg
mbl
three
mg
dose
given
iv
week
period
week
show
advers
clinic
chang
sign
infusionassoci
complement
activ
studi
suggest
infus
purifi
mbl
prepar
staten
serum
institut
ssi
safe
howev
adult
given
least
mg
twice
thrice
weekli
maintain
protect
mbl
level
assum
ngml
valdimarsson
et
al
consider
mbl
genotyp
associ
infect
open
possibl
produc
clinic
grade
recombin
mbl
result
establish
compani
aim
jenseniu
et
al
treatment
chronic
disord
may
possibl
also
consid
longer
term
invent
led
use
least
mbl
oligom
compris
least
one
mbl
subunit
manufactur
medica
prophylaxi
andor
treatment
infect
thiel
jenseniu
